Carcinoma, Embryonal clinical trials

The registry lists 35 studies for Carcinoma, Embryonal across more than 10 countries. 3 are recruiting or about to start. 1 of them are mainly about Carcinoma, Embryonal (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-23.

Get an email when these change. Save the Carcinoma, Embryonal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Recruiting: 3
Terminated: 2
Status unknown: 1

Phase

Phase 2: 18
Phase 3: 11
Phase 1: 3

Where

United States: 27
United Kingdom: 7
Canada: 4
Italy: 4
Slovakia: 4
Australia: 4

Who runs them

Fred Hutchinson Cancer Center (7) · Memorial Sloan Kettering Cancer Center (5) · Children's Oncology Group (4) · European Organisation for Research and Treatment of Cancer - EORTC (3) · Medical Research Council (2) · National Cancer Institute (NCI) (2) · Nabil Adra (1) · Fondazione Michelangelo (1)

What is being tested here

Drugs under test in Carcinoma, Embryonal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Carboplatin	1	1	4
Etoposide	1	2	4
Cisplatin	1	1	3
Thiotepa	1	0	2
Bleomycin	1	1	1
Paclitaxel	0	3	8
Ifosfamide	0	2	7
Filgrastim	0	0	3
Brentuximab Vedotin	0	0	2
Pegfilgrastim	0	0	2

Drug classes tested here Alkylating agents 1 open · Antimitotic agents 9

Coming up

1phase 3 study under way

2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Jun 2027Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · Phase 3 · Children's Oncology Group
Jun 2027Molecular Epidemiology of Pediatric Germ Cell Tumors · Children's Oncology Group

Who these studies take

Of the 3 Carcinoma, Embryonal studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	3 (100%)	3 (100%)
18	3 (100%)	3 (100%)
30	2 (67%)	2 (67%)
40	2 (67%)	2 (67%)
50	2 (67%)	2 (67%)
65	2 (67%)	2 (67%)
75	2 (67%)	2 (67%)
85	2 (67%)	2 (67%)

Across all 35 studies, recruiting or not: 31% stop at 75 or younger and 20% at 65; 71% take children; 0% are for women only and 29% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 35 of 35. search them.